Quidel Reports $50M in Preliminary Revenues for Q4, Topping Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Quidel said after the close of the market on Wednesday that revenues for the fourth quarter of 2013 are expected to total about $50 million.

The figure would represent a 7 percent drop from Q4 2012 revenues of $53.9 million, but it beats the consensus Wall Street estimate of $48.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.